Publications by authors named "Zubo Tu"

With the increasing aging population, the demand for orthopedic implants is also growing. Polyether ether ketone (PEEK) is considered a promising material for orthopedic implants due to its excellent biocompatibility. However, the lack of bioactivity and excessive immune response post-implantation often impair bone integration.

View Article and Find Full Text PDF

Background: The physiological and immunological characteristics of the tumor microenvironment (TME) have a profound impact on the effectiveness of immunotherapy. The present study aimed to define the TME subtype of osteosarcoma according to the signatures representing the global TME of the tumor, as well as create a new prognostic assessment tool to monitor the prognosis, TME activity and immunotherapy response of patients with osteosarcoma.

Methods: The enrichment scores of 29 functional gene expression signatures in osteosarcoma samples were calculated by single sample gene set enrichment analysis (ssGSEA).

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Zubo Tu"

  • - Zubo Tu's research focuses on enhancing orthopedic implants and understanding tumor microenvironments, particularly in relation to immunomodulation and osseointegration, as evidenced by his recent work on Ga-doped mesoporous bioactive glass-integrated PEEK implants aimed at improving bone integration and reducing immune responses.
  • - In his study on osteosarcoma, Tu explores the tumor microenvironment (TME) characteristics to assess their impact on immunotherapy effectiveness, leading to the development of a new prognostic evaluation tool that correlates TME subtypes with patient outcomes.
  • - Tu employs advanced analytical techniques, such as single sample gene set enrichment analysis (ssGSEA), to define TME subtypes and their respective influences on therapeutic responses, emphasizing the importance of personalized medicine in treating aggressive cancers like osteosarcoma.